Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Mooberry

Showing results (1-10 of 120) with videos related to

Pageof 12
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 28, 2004
Mechanism of action of 2-methoxyestradiol: new developmentsSusan L Mooberry
Current Opinion in Oncology|November 19, 2003
New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agentSusan L Mooberry
Methods in Molecular Medicine|December 19, 2007
Strategies for the development of novel Taxol-like agentsSusan L Mooberry
Natural Product Reports|February 1, 2014
Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activitiesCristina C Rohena, Susan L Mooberry
Cell Cycle (Georgetown, Tex.)|May 21, 2011
Cellular studies reveal mechanistic differences between taccalonolide A and paclitaxelApril L Risinger, Susan L Mooberry
Cancer Letters|November 3, 2009
Taccalonolides: Novel microtubule stabilizers with clinical potentialApril L Risinger, Susan L Mooberry
Journal of Natural Products|January 31, 2006
Hurghadolide A and swinholide I, potent actin-microfilament disrupters from the Red Sea sponge Theonella swinhoeiDiaa T A Youssef, Susan L Mooberry
Bioorganic & Medicinal Chemistry|February 5, 2014
Taccalonolide microtubule stabilizersJing Li, April L Risinger, Susan L Mooberry
British Journal of Cancer|September 5, 2019
Eribulin rapidly inhibits TGF-β-induced Snail expression and can induce Slug expression in a Smad4-dependent mannerRoma Kaul, April L Risinger, Susan L Mooberry
Journal of Natural Products|March 6, 2019
Microtubule-Targeting Drugs: More than AntimitoticsRoma Kaul, April L Risinger, Susan L Mooberry
Pageof 12

Showing results (1-10 of 120) with videos related to

Sort By:
Pageof 12
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 28, 2004
Mechanism of action of 2-methoxyestradiol: new developmentsSusan L Mooberry
Current Opinion in Oncology|November 19, 2003
New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agentSusan L Mooberry
Methods in Molecular Medicine|December 19, 2007
Strategies for the development of novel Taxol-like agentsSusan L Mooberry
Natural Product Reports|February 1, 2014
Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activitiesCristina C Rohena, Susan L Mooberry
Cell Cycle (Georgetown, Tex.)|May 21, 2011
Cellular studies reveal mechanistic differences between taccalonolide A and paclitaxelApril L Risinger, Susan L Mooberry
Cancer Letters|November 3, 2009
Taccalonolides: Novel microtubule stabilizers with clinical potentialApril L Risinger, Susan L Mooberry
Journal of Natural Products|January 31, 2006
Hurghadolide A and swinholide I, potent actin-microfilament disrupters from the Red Sea sponge Theonella swinhoeiDiaa T A Youssef, Susan L Mooberry
Bioorganic & Medicinal Chemistry|February 5, 2014
Taccalonolide microtubule stabilizersJing Li, April L Risinger, Susan L Mooberry
British Journal of Cancer|September 5, 2019
Eribulin rapidly inhibits TGF-β-induced Snail expression and can induce Slug expression in a Smad4-dependent mannerRoma Kaul, April L Risinger, Susan L Mooberry
Journal of Natural Products|March 6, 2019
Microtubule-Targeting Drugs: More than AntimitoticsRoma Kaul, April L Risinger, Susan L Mooberry
Pageof 12